Pharmacological implications of brain acetylcholine turnover measurements in rat brain nuclei.
D000109:Acetylcholine / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism*; D000701:Analgesics, Opioid / Q000494:pharmacology; D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001923:Brain Chemistry; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D002794:Choline / Q000378:metabolism; D006213:Hallucinogens / Q000494:pharmacology; D066298:In Vitro Techniques; D007553:Isotope Labeling; D007700:Kinetics; D010276:Parasympatholytics / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D010767:Phosphorylcholine / Q000378:metabolism; D011180:Postmortem Changes; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects; D012964:Sodium / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D000701:Analgesics, Opioid; D000777:Anesthetics; D001463:Barbiturates; D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D010276:Parasympatholytics; D010277:Parasympathomimetics; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D010767:Phosphorylcholine; D005680:gamma-Aminobutyric Acid; D012964:Sodium; D002794:Choline; D000109:Acetylcholine